Kenalog 40 Injection (40 mg per 1 mL) Single-dose Vial (Rx)

Kenalog 40 Injection (40 mg per 1 mL) is a corticosteroid used to treat various conditions involving inflammation and allergic reactions, such as arthritis, bursitis, and skin diseases. It works by decreasing the body's immune response, thereby reducing swelling, redness, and pain. Administered typically via intramuscular or intra-articular injection, Kenalog 40 is effective in managing symptoms of chronic conditions and providing relief from acute inflammatory episodes, contributing to improved mobility and quality of life for patients.

Features and Benefits:

• High effectiveness in providing long-term relief from the symptoms associated with certain inflammatory conditions, such as allergies, skin conditions, and joint pain.
• Fast onset of action compared to other medications, with maximal effect achieved within 2-7 days.
• Low risk of side effects, such as nausea, headache, dizziness, weakness, and changes in weight.
• Can be used as a long-term maintenance therapy to keep symptoms under control.
• Cost-effective due to its low cost compared to other treatments for chronic inflammatory conditions.
• Can be easily administered by a healthcare professional in just one injection session.

Product Details:

Active Ingredient: Triamcinolone Acetonide, 40 mg per mL.
Formulation: Injectable suspension for intramuscular or intra-articular administration.

Indications:

• Used to manage a wide range of conditions including allergic reactions, dermatologic diseases, rheumatic disorders, and other systemic inflammatory and autoimmune disorders that are responsive to systemic corticosteroids.

Mechanism of Action:

Triamcinolone acetonide works by suppressing the immune response and decreasing inflammation by reducing the release of inflammatory substances in the body.

Administration Instructions:

• Administered via intramuscular (IM) or intra-articular injection by a healthcare professional.
  
• Dosage and frequency depend on the specific condition being treated and patient response.

Packaging: Available as single-dose vials containing 1 mL of injectable suspension.

Storage:

• Store at controlled room temperature, 20° to 25°C (68° to 77°F).
  
• Protect from light and freezing.
  
• Use immediately after opening and discard any unused portion.

Precautions:

• For professional use only; must be administered under medical supervision.
  
• Use with caution in patients with known hypersensitivity to corticosteroids.
  
• Not recommended for use in systemic fungal infections or for patients receiving live or attenuated vaccines.

Potential Side Effects:

• May cause localized reactions such as pain or swelling at the injection site.
• Systemic effects can include increased susceptibility to infections, mood changes, and endocrine disturbances.
• Long-term use may result in additional side effects; regular monitoring by a healthcare provider is advised.

Each mL of the sterile aqueous suspension provides 40 mg triamcinolone acetonide, with 0.65% sodium chloride for isotonicity, 0.99% (w/v) benzyl alcohol as a preservative, 0.75% carboxymethylcellulose sodium, and 0.04% polysorbate 80. Sodium hydroxide or hydrochloric acid may be present to adjust pH to 5.0 to 7.5. At the time of manufacture, the air in the container is replaced by nitrogen.

Kenalog 40 Injection by Bristol Myers Squibb is a trusted therapeutic tool for medical professionals seeking efficient and dependable relief from inflammation and allergic reactions. Ensure it is administered by qualified professionals to maximize patient safety and therapeutic outcomes.